Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma

NCT00976573 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

149

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: bevacizumab
DRUG: carboplatin
DRUG: everolimus
DRUG: paclitaxel

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]